tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Wangzhi Li, 12 are a BUY (80%), 3 are a HOLD (20%).
Analyst Wangzhi Li, currently employed carries an average stock price target met ratio of 65% that have a potential upside of 64.71% achieved within 187 days. Previously, Wangzhi Li worked at LADENBURG.
Wangzhi Li’s has documented 32 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BGNE, BeiGene Ltd at 08-Dec-2020.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 3/4/2020. The price target of $28 was fulfilled within 54 days with a profit of $11.22 (66.87%) receiving and performance score of 12.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$300
$120.65 (67.27%)
$319
15 days ago
(03-Dec-2024)
3/10 (30%)
$93.22 (45.08%)
126
Buy
$260
$80.65 (44.97%)
$254
1 months 5 days ago
(13-Nov-2024)
4/8 (50%)
$61.6 (31.05%)
125
Buy
$288
$108.65 (60.58%)
$285
4 months 10 days ago
(08-Aug-2024)
0/4 (0%)
$104.97 (57.35%)
Hold
$164.3
$-15.05 (-8.39%)
$212
8 months 10 days ago
(08-Apr-2024)
3/3 (100%)
$14.55 (9.72%)
135
Buy
$345
$165.65 (92.36%)
$350
9 months 21 days ago
(27-Feb-2024)
2/5 (40%)
$165.31 (92.00%)
350
What Year was the first public recommendation made by Wangzhi Li?
